Sciencast Management LP Makes New Investment in Cigna Group $CI

Key Points

• Sciencast Management LP acquired 6,225 shares of Cigna Group, valued at approximately $2,048,000, during the first quarter, highlighting significant institutional interest in the stock.
• Cigna Group reported $7.20 earnings per share (EPS) for the last quarter, surpassing analysts' expectations and achieving a revenue of $67.13 billion, an 11% year-over-year increase.
• The company declared a quarterly dividend of $1.51 per share, with an annualized dividend yield of 2.0%, reflecting its commitment to returning value to shareholders.

Sciencast Management LP bought a new stake in Cigna Group (NYSE:CI - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 6,225 shares of the health services provider's stock, valued at approximately $2,048,000.

A number of other large investors have also made changes to their positions in CI. 1248 Management LLC purchased a new position in Cigna Group during the 1st quarter worth $29,000. Activest Wealth Management boosted its holdings in Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock worth $30,000 after acquiring an additional 72 shares in the last quarter. Putney Financial Group LLC purchased a new stake in shares of Cigna Group during the fourth quarter worth about $36,000. Saudi Central Bank acquired a new position in shares of Cigna Group during the first quarter valued at about $36,000. Finally, Evermay Wealth Management LLC raised its position in shares of Cigna Group by 58.6% in the 1st quarter. Evermay Wealth Management LLC now owns 111 shares of the health services provider's stock valued at $37,000 after purchasing an additional 41 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Guggenheim reissued a "buy" rating and set a $350.00 target price (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Cantor Fitzgerald reissued an "overweight" rating and set a $365.00 price objective on shares of Cigna Group in a report on Tuesday, August 26th. Wall Street Zen lowered Cigna Group from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Barclays boosted their price target on Cigna Group from $354.00 to $383.00 and gave the company an "overweight" rating in a research note on Thursday, September 4th. Finally, Robert W. Baird set a $372.00 price objective on Cigna Group in a research note on Thursday, August 14th. Two analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group presently has a consensus rating of "Buy" and a consensus price target of $374.76.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares of the company's stock, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.70% of the company's stock.

Cigna Group Stock Performance

Shares of CI stock traded up $3.49 on Thursday, hitting $305.93. The company had a trading volume of 1,443,759 shares, compared to its average volume of 1,819,749. The firm has a market cap of $81.66 billion, a P/E ratio of 16.70, a price-to-earnings-growth ratio of 0.88 and a beta of 0.48. The company has a 50-day moving average price of $296.08 and a 200-day moving average price of $312.04. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a twelve month low of $256.89 and a twelve month high of $370.83.

Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company's revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Investors of record on Thursday, September 4th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group's payout ratio is currently 32.97%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.